$BIVI
BioVie, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.30
▲+8.33%+$0.100
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBioVie, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is BIVI up today? It is at $1.30 (+8.33%), and our scanner flagged it 27 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BIVI spikes, and full due diligence on BIVI — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BIVI 27 times in the last 30 days. Create a free account to track $BIVI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BIVI from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kim Joanne Wendy Officer | Bought (open market) | +3K 0.03% of company | added 100% | 3K | $5K at $2.18 | Aug 28, 26 |
Chappell Amy Suzon Director | Bought (open market) | +727 | n/a | 727 | $2K at $2.16 | Aug 28, 26 |
Palumbo Joseph M Officer | Bought (open market) | +5K 0.06% of company | added 100% | 6K | $10K at $2.16 | Aug 28, 26 |
Do Cuong V Officer | Bought (open market) | +15K 0.2% of company | added 100% | 16K | $32K at $2.08 | Aug 27, 26 |
Do Cuong V Officer | Acquired (grant/award) | +5K 0.07% of company | added 100% | 10K | n/a | Aug 7, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on BIVI from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
BIVI last traded at $1.30, up 8.33% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
BioVie, Inc. Common Stock (BIVI) is next expected to report earnings on Monday, November 9, 2026, about 22 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The BIVI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BIVI 27 times in the last 30 days.
BIVI (BioVie, Inc. Common Stock) trades on XNAS, with a market cap of about $9M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BIVI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BIVI discussion
Sign in to ask a question or join the discussion.